Nevada has been relatively active in the most recent legislative term on healthcare price transparency, costs, and markets. Nevada’s primary effort in healthcare transparency and cost containment in 2017 was the Nevada Care Plan, which would have allowed anyone without health insurance buy into the state’s Medicaid program. Because of Medicaid’s low reimbursement rates for doctors and other health-care providers, it may have provided an economical alternative to private insurance, though at the cost of narrower provider options. The bill creating this new Medicaid buy-in cleared the legislature, but was vetoed by Republican Governor Brian Sandoval.
Nevada also gained widespread attention as the first state to target medicines for a specific ailment, passing SB 539 which requires more transparency from drug makers over their pricing of diabetes medicines. The pharmaceutical industry pushed back with a lawsuit claiming the transparency law is unprecedented and unconstitutional, because it interferes with well-established patent law by robbing drug makers of their right to protect trade secrets. The case is outstanding in Nevada District Court.
2020 Legislative Session: Not in session. *Legislature convenes in odd number years only.
STATE BUDGETThe Nevada state budget operates on a biennium cycle, covering two fiscal years. Nevada’s fiscal year begins on July 1 and ends on June 30 of the following year.
REGULATION & ENFORCEMENT
- Nevada was one of 16 states to file an amicus brief supporting the FTC’s winning position in the Ninth Circuit appeal of St. Luke’s Health Care Sys. v. FTC, No. 14-35173 (March 7, 2014), decided February 10, 2015. The States’ brief stated that the acceleration of health care costs due to the growth of large health care provider systems had become a matter of grave concern for the states.